- Home
- SGP vs ITRG Comparison
SGP vs ITRG Comparison
Compare SGP & ITRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SGP | ITRG |
|---|---|---|
| Founded | 2019 | 1997 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 932.9M | 874.5M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | SGP | ITRG |
|---|---|---|
| Price | $26.68 | $3.68 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $47.00 | $5.13 |
| AVG Volume (30 Days) | 82.4K | ★ 2.3M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $733.38 |
| Revenue Next Year | N/A | $46.00 |
| P/E Ratio | ★ N/A | $45.07 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $24.71 | $1.03 |
| 52 Week High | $30.56 | $4.87 |
Technical Indicators
Market Signals| Indicator | SGP | ITRG |
|---|---|---|
| Relative Strength Index (RSI) | 53.08 | 43.44 |
| Support Level | $25.50 | $3.27 |
| Resistance Level | $30.02 | $4.71 |
| Average True Range (ATR) | 1.60 | 0.25 |
| MACD | -0.30 | -0.01 |
| Stochastic Oscillator | 29.00 | 39.00 |
Price Performance
Historical ComparisonAbout SGP SpyGlass Pharma Inc. Common Stock
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.
About ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.